Abbott Laboratories (NYSE:ABT) on 06/14/2019 declared a dividend of $ 0.3200 per share payable on August 15, 2019 to shareholders of record as of July 15, 2019.

Abbott Laboratories (NYSE:ABT) has paid dividends since 1926, has a current dividend yield of 1.5554745197% and has increased its dividends for 5 successive years.

Abbott Laboratories's market cap is $ 145,174,454,490 and has a PE ratio of 55.60. The stock price closed yesterday at $ 82.29 and has a 52 week low/high of $ 60.32 and $ 82.33.

Abbott Laboratories discovers, develops, manufactures and sells of a range of health care products. Co.'s reportable segments are: established pharmaceutical products, which include a range of generic pharmaceuticals; diagnostic products, which include a range of diagnostic systems and tests; nutritional products, which include a range of pediatric and adult nutritional products; and Cardiovascular and neuromodulation products, which include a range of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, as well as neuromodulation devices for the management of chronic pain and movement disorders.

For more information on Abbott Laboratories click here.